Cardiology

Long-term data from the SAFE-PAD trial at SCAI 2022 underlines the noninferiority of paclitaxel-coated devices versus non-drug-coat devices for use in patients with peripheral artery disease.

An analysis of data from the Fuwai PCI registry details the incidence of adverse events and risk of bleeding associated with clopidogrel monotherapy versus aspirin monotherapy 12 months post-PCI in high-risk patients.

Chair of the SCAI's writing group for their 2022 guidelines on management of patent foramen ovale, Dr. Clifford Kavinsky, sits down with Practical Cardiology to take part in a Q&A on the guideline's recommendations and the writing process for the SCAI's first PFO guidance.

Dr Amy Pollak shares her thoughts on risk-benefit analysis when evaluating patients with high thrombotic/bleeding risk and treatment selection.

Dr Eric Secemsky discusses how use of stents has evolved over the years in treatment of polyvascular disease.

New data suggest pediatric patients with a history of cardiac arrest are highly susceptible to hospitalization if infected with SARS-CoV-2.

A study from SCAI 2022 details the rate and safety of percutaneous coronary intervention among patients with active cancer and thrombocytopenia in the US from 2016-2018.

Diabetic ketoacidosis increased the likelihood of in-hospital mortality by 61%, the likelihood of major adverse cardiovascular events by 56%, and a likelihood of 30-day readmission by 12% among patients hospitalized with heart failure in the US.

Both exogenous hyperthyroidism and exogenous hypothyroidism were associated with increased risk of cardiovascular mortality.

This model was responsible for correctly identifying 73% of patients with pulmonary arterial hypertension 6 months prior to a confirmed diagnosis.

The media campaign to improve aspirin use included billboards, radio ads and print articles, in addition to a dedicated website.

A Massachusetts General Hospital investigator explains how the innovative DCD practice addresses both waitlist issues and transplant center's capabilities.

Our latest cardiology case report features a woman in her mid-70s with a history of hypertension presenting to the hospital with intermittent palpitations as well as worsening bedsores. Check out the EKG and determine the correct diagnosis!

Metabolomic analyses of data from more than 200 women from a team of European investigators detail the impact of hormonal shifts associated with the transition to menopause on cardiovascular risk.

The new drug-eluding stent can provide more flexible width size for patients with the potentially deadly disease.

Announced on May 13, the Onyx Frontier DES carries the same clinical indications as Medtronic's Resolute Onyx DES and will be available in 2.0 mm sizes as well as 4.50-5.00 mm sizes that can be expanded to 6.00 mm.

Dr Manesh Patel and other experts discuss the role of dual antiplatelet therapy (DAPT) in treatment of coronary artery disease.

Drs Marc Bonaca and Deepak Bhatt discuss the role of therapy intensification when managing high-risk patients with polyvascular disease.

Among patients with early-onset AF, the presence of disease-associated rare variants in CM and arrhythmia genes was associated with a 1.5-fold higher risk of mortality over 10 years.

Aortic sclerosis, trace or mild aortic regurgitation, and mild mitral regurgitation each had significant associations with CV risk.

Targeting a blood pressure of less than 140/90 mm Hg was associated with better pregnancy outcomes than reserving treatment for severe hypertension.

Adolescents with a GLP-1 RA prescription within year of T2D diagnosis were more probable to be in better glycemic control and less probable to be prescribed insulin.

After adjustment for known cardiovascular risk factors, investigators found women with a hypertensive disorder of pregnancy, including preeclampsia and gestational hypertension, during their first pregnancy had a 63% greater risk of future cardiovascular disease compared to women with normotensive pregnancies.

A discussion into available pharmacotherapy for obesity and the uptake in practice of newer agents.

These findings suggest the importance of COVID-19 vaccination for patients with OHT.

The prevalence of sleep-disordered breathing differed across various etiologies of heart failure.

There was no statistically significant difference in mean systolic blood pressure for the self-monitoring groups vs the usual care group.

Treating 100 older patients (≥60 years) with hypertension for approximately 3 years would prevent 1 major adverse cardiovascular event.

Sleep disordered breathing is frequently cited in patients with heart failure due to multiple factors included hypoxemia, sympathetic activation and systematic inflammation.

The study authors used data from Medicare beneficiaries who survived a heart attack between 1995 and 2019.